TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
SVAR Life Science AB
Closing information (x1000 DKK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 177,608 | 161,345 | 152,954 |
Financial expenses | 5,411 | 5,001 | 9,983 |
Earnings before taxes | 30,242 | -25,593 | -5,591 |
EBITDA | 31,928 | 28,192 | -3,030 |
Total assets | 186,954 | 177,153 | 213,560 |
Current assets | 116,267 | 74,817 | 65,485 |
Current liabilities | 39,249 | 37,588 | 45,429 |
Equity capital | 130,086 | 109,601 | 127,489 |
- share capital | 196 | 213 | 217 |
Employees (average) | 120 | 123 | 90 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 69.6% | 61.9% | 59.7% |
Turnover per employee | 1,480 | 1,312 | 1,699 |
Profit as a percentage of turnover | 17.0% | -15.9% | -3.7% |
Return on assets (ROA) | 19.1% | -11.6% | 2.1% |
Current ratio | 296.2% | 199.0% | 144.1% |
Return on equity (ROE) | 23.2% | -23.4% | -4.4% |
Change turnover | 29,332 | 11,287 | -34,191 |
Change turnover % | 20% | 8% | -18% |
Chg. No. of employees | -3 | 33 | -40 |
Chg. No. of employees % | -2% | 37% | -31% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.